Candel Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
CADL
CUSIP
137404109
Type
Equity
Class
COM
Num filings
52
Total reported value, excl. options
$37.2 M
Manager Report Date Value ($000) Shares Option Type